Citicoline sodium CAS 33818-15-4
Pyrroloquinoline quinone acid CAS 72909-34-3
27 5 月, 2020Antioxidant 245 CAS 36443-68-2
27 5 月, 2020
Citicoline sodium Typical Properties
| Appearance | White crystalline or crystalline powder, odorless |
| Assay | ≥98.0% |
| PH | 6.0~7.5 |
| Chlorides | ≤0.05% |
| Ammonium salt | ≤0.05% |
| Iron | ≤0.01% |
| Phosphates | ≤0.1% |
| Loss on drying | ≤6.0% |
| Heavy metals | ≤0.0005% |
| Bacterial endotoxins | <0.30EU/mg |
| Brand name | Fousi chemical |
Citicoline sodium Usage
- This product belongs to the central nervous system.
- This product is a coenzyme. For acute craniocerebral trauma and postoperative consciousness disturbance. Acute craniocerebral trauma and unconsciousness after brain surgery, hemiplegia caused by stroke can gradually restore the function of the limbs, can also be used for other central nervous system acute injury caused by functional and consciousness disorders, also used for ischemic cerebrovascular disease And vascular dementia.
- Citicoline sodium can enhance the brainstem network structure, especially the function of the upward network structure activation system closely related to consciousness, enhance the role of the pyramidal system, inhibit the role of the extrapyramidal system, and promote recovery. At the same time, it can reduce cerebral vascular resistance, increase cerebral blood flow perfusion, and promote brain material metabolism.
Citicoline sodium Packaging and Shipping
Packing: 25KG/BAG
Citicoline sodium Storage
Store in cool and ventilated storeroom. The temperature should not exceed 37°C. Should be stored separately with oxidants, edible chemicals, avoid mixed storage